Découvrez le nouveau Chem-Impex : là où l'innovation commence par une liaison.

Catalog Number:
38283
CAS Number:
50-35-1
±)-Thalidomide
Purity:
≥ 98 % (HPLC)
Synonym(s):
N- (2,6-dioxo-3-pipéridinyl)phtalimide
Hazmat
Documents
$189.58 /1G
Taille
Request Bulk Quote
Informations sur le produit

(±)-Thalidomide is a compound renowned for its multifaceted applications in the pharmaceutical industry, particularly in the treatment of various conditions such as multiple myeloma and leprosy. Originally developed as a sedative, its unique properties have led to its repurposing as an immunomodulatory agent, making it invaluable in managing inflammatory diseases and certain cancers. Researchers and healthcare professionals appreciate its ability to inhibit angiogenesis and modulate immune responses, which is crucial in developing targeted therapies.

In addition to its therapeutic uses, (±)-Thalidomide has garnered attention for its role in clinical research, particularly in understanding the mechanisms of drug action and the development of novel treatment protocols. Its effectiveness in combination therapies further enhances its appeal, providing a synergistic approach to patient care. With a well-documented safety profile when used appropriately, (±)-Thalidomide continues to be a significant compound in modern medicine, offering hope and improved outcomes for patients worldwide.

Numéro CAS 
50-35-1
Formule moléculaire
C13H10N2O4
Poids moléculaire 
258.23
Point de fusion 
275 - 277 ?C
Informations générales
Numéro CAS 
50-35-1
Formule moléculaire
C13H10N2O4
Poids moléculaire 
258.23
Point de fusion 
275 - 277 ?C
Propriétés
Informations complémentaires sur la propriété à venir prochainement !
-
Sécurité et réglementation
Matières dangereuses
-
Antibiotique
-
Réglementé par la DEA
Non
Avertissements 
-
Applications

(±)-Thalidomide is widely utilized in research focused on

  • Multiple Myeloma Treatment: This compound is approved for treating multiple myeloma, a type of blood cancer. Its ability to inhibit tumor growth and modulate the immune system makes it a valuable option for patients.
  • Leprosy Management: Thalidomide is effective in treating complications of leprosy, particularly erythema nodosum leprosum, providing relief from painful skin lesions and inflammation.
  • Anti-Inflammatory Applications: Due to its immunomodulatory properties, it is used in treating various inflammatory conditions, including Crohn's disease and ulcerative colitis, offering an alternative for patients who do not respond to conventional therapies.
  • Research in Angiogenesis: Thalidomide is studied for its role in inhibiting angiogenesis, the formation of new blood vessels, which is crucial in cancer progression and other diseases, making it a key focus in cancer research.
  • Potential in Autoimmune Disorders: Ongoing research is exploring its use in autoimmune diseases like lupus and rheumatoid arthritis, where it may help modulate the immune response and reduce symptoms.

Citations